The Centers for Medicare & Medicaid Services on Tuesday unveiled its coverage plans for Biogen's Alzheimer's treatment aducanumab, proposing coverage only for individuals taking the controversial drug as part of approved clinical trials.
The Centers for Medicare & Medicaid Services on Tuesday issued surveyor guidance on assessing long-term care facilities’ compliance with a federal mandate for healthcare worker COVID-19 vaccinations.
Nearly 51% of fully vaccinated nursing home residents have received a booster shot, according to new data released by the Centers for Disease Control and Prevention.